Consumer Products Startups funded by Y Combinator (YC) 2026

One memory for your team's agents. Turn every meeting, Claude session, and Slack chat into context your team and agents share.

Juno is an AI personal health assistant for the 1B+ people living with chronic illness. Juno builds a longitudinal health profile from conversations, biometrics, and medical history to identify patterns behind symptoms and provide tailored guidance. Isaac and Marshall started building Juno after growing up with chronic conditions and spending years trying to understand their symptoms. Like millions of others, they waited months for appointments and struggled to explain complex medical history in 15 minutes. As a result, key signals are missed, contributing to an average diagnosis time of 7.6 years. Even after receiving a diagnosis, patients are often left without a clear treatment plan and have to manage their condition alone. Many use AI chatbots for support, but without context on their medical history or symptom progression, they receive generic advice that is rarely actionable. Juno solves this by building a continuous, structured health profile for each user and connecting this fragmented health information. We spent the last year conducting research at Oxford and UCL to build our proprietary engagement layer for daily conversations, allowing Juno to ask the right questions at the right time and understand each user's health better than anyone else ever could. We launched in October and are already at $600k in annual run rate, supporting 50,000+ patients globally. We’re building a future where everyone has a private clinical specialist in their pocket, 24/7.

AI-powered product compliance platform that makes it easy for retailers to launch and scale products across borders without drowning in regulatory work. Complir's AI agents handle the regulations and documentation across every market you sell in - and keep your entire catalogue audit-ready.

Stratify is the AI-powered user researcher that discovers the why behind every decision, click, and preference. Our platform uses agentic workflows that instantly recruit participants, conduct user interviews, analyze responses, and provide actionable insights.

ThirdLayer is an applied research and product lab building the next interface for human–AI collaboration. Our first product is Dex, an AI copilot for the browser. Think Cursor for knowledge work, optimized for speed and embedded directly where you work. Most web agents are built for set-and-forget tasks. But real work is fluid and messy—spread across tabs, tools, and evolving decisions. Dex transforms your browser into an intelligent, multimodal workspace that understands your intent through voice, text, and action. It enhances familiar interfaces, automates tedious steps, and removes the friction of handoffs. Beneath the surface, Dex is more than a browser agent — it’s a foundation for: ● Long-term, cross-modal memory grounded in real workflows ● A new interaction layer to replace static UI with a collaborative canvas ● Personalization: understanding how individuals approach tasks and navigate software We're building the infrastructure for adaptive, intent-aware systems that work the way you do.

Digital health holds a lot of potential but is ignoring a growing problem: diagnostic testing. Without this data, providers and organizations will be limited in the services they can provide patients at home. Scout has developed a platform - Hub, test kits, and app - that delivers health testing at home with 10x lower development cost and 3x lower per-test price. Our patented tech also meets performance requirements for medical diagnoses and integrates with the current healthcare tech stack. Scout’s technology is poised to disrupt the outdated $33Bn diagnostic market by democratizing testing while dramatically improving the patient experience. Scout has received $16M in non-dilutive funding from the NIH and other organizations to fully de-risk our platform, and our pipeline includes a diverse test menu for primary care (e.g. respiratory and sexual health), wellness (e.g. gut health), and chronic conditions (e.g. certain cancers). We have already received FDA authorization for our platform in clinical settings and are planning to launch our flagship Scout Hub in 2024.

Liv Labs (@livlabsfitness) is a US-based, Y Combinator-backed women's wellness innovator. 78 million American women live with pelvic floor weakness and 31M worry daily about leaking. Liv Labs is commercializing the patented Pippa Resistance Spring to boost fitness during exercise and semi-automated self-care coaching to keep them strong and active, lifelong. First orders shipped October 11, 2025. Pippa inventor, Carly Price, reimagined the humble pillow for Casper and has 41 patents to her name. Company CEO, Melody Roberts, incubated digital service experiences now scaling globally at McDonald's and Panera. Pippa development has been substantially funded by non-dilutive SBIR grants from NIH, NSF, and State of Illinois, based on stellar product effectiveness data and user feedback like, "With this, surgery is off the table." 

aSim lets you build and share apps with friends. Prompt > Run > Remix > Repeat, and you'll have the next TikTok in no time.

We are on a mission to help people understand what influence how they feel and what they can do to feel better. Stoic has more than 4 000 000 downloads, 100 000+ reviews with a 4.8/5 average and you can find it here http://apple.co/-stoic and here http://apple.co/stoic

AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.

MailTime Email Messenger: Mobile email client that makes emails as quick and easy as texting. MailTime AI: Draft and proofread emails using generative AI.